The study found that POM121 nucleoporin, which blocks the growth rate of prostate cancer

Copyright © iCell Bioscience Inc, Shanghai 2018-2019

Prostate cancer remains a major health challenge for scientists, and it is also the second leading cause of cancer deaths in American men. Researchers have identified a new method to target the treatment of malignant prostate cancer, and specific molecular drivers that drive cancer growth are often not undruggable.

Researchers have also been unable to develop specific compounds to block the activity of these molecular drivers and inhibit cancer growth, many of which work by transmitting cancer-promoting information into a special "inlet" in the nucleus, in the nucleus. The information instruction will be executed.

Recently, a research report published in the international magazine Cell, scientists from Thomas Jefferson University discovered a new method to block the nuclear "gates" used by these molecules. Inhibition can slow the progression of prostate cancer in the body of mice bearing human tumors.